Original Research

Published on 06 Apr 2023

The prognostic value of postoperative radiotherapy in right tumor for lung related death: based on SEER database and real-world data

in Cancer Immunity and Immunotherapy

You Mo
Minxin Chen
Minglei Wang
Meng Wu
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1178064

1,464 views

Original Research

Published on 06 Apr 2023

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor

in Cancer Immunity and Immunotherapy

Lin Cai
Yu Du
Kai Song
Peng Peng
Fei Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1148498

1,336 views
1 citation

Case Report

Published on 05 Apr 2023

Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review

in Cancer Immunity and Immunotherapy

Hujuan Yang
Zhiquan Qin
Xianglei He
Qian Xue
Hongying Zhou
Jie Sun
Xiaoyi Li
Tongwei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1110997

1,296 views

Original Research

Published on 05 Apr 2023

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma

in Cancer Immunity and Immunotherapy

Baodong Wang
Mei Li
Rongshan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1169395

1,950 views

Original Research

Published on 05 Apr 2023

By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma

in Cancer Immunity and Immunotherapy

Guang Xia
Song Wu
Ke Luo
Xiaoyu Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1180191

1,804 views

Original Research

Published on 05 Apr 2023

Murine macrophage-based iNos reporter reveals polarization and reprogramming in the context of breast cancer

in Cancer Immunity and Immunotherapy

Javier A. Mas-Rosario
Josue D. Medor
Mary I. Jeffway
José M. Martínez-Montes
Michelle E. Farkas

Frontiers in Oncology

doi 10.3389/fonc.2023.1151384

1,855 views
2 citations

Review

Published on 04 Apr 2023

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy

in Cancer Immunity and Immunotherapy

Wei Zhang
Xiaoqiang Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1122322

1,975 views

Original Research

Published on 04 Apr 2023

Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination

in Cancer Immunity and Immunotherapy

Zhong Liu
Feng Zhang
Jianwen Jiang
Chenzhao Zhao
Lu Zhu
Chenbing Liu
Nan Li
Lihong Qiu
Chao Shen
Di Sheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1166894

855 views

Editorial

Published on 03 Apr 2023

Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation

in Cancer Immunity and Immunotherapy

Petros Christopoulos
Udo S. Gaipl

Frontiers in Oncology

doi 10.3389/fonc.2023.1182081

731 views
1 citation

Original Research

Published on 30 Mar 2023

Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Zhixin Liu
Shuai Chen
Wenming Jia
Ye Qian
Xiaoqi Yang
Minfa Zhang
Tianhe Fang
Heng Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1113781

2,122 views
1 citation

Original Research

Published on 30 Mar 2023

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis

in Cancer Immunity and Immunotherapy

Xiushen Li
Xi Yang
Weiqi Xue
Rui Yang
Zhiwei He
Lisha Ai
Hui Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1119763

1,762 views
1 citation

Original Research

Published on 29 Mar 2023

Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients

in Cancer Immunity and Immunotherapy

Yixiao Liu
Bo Jin
Cheng Shen
Xianshu Gao
Xin Qi
Mingwei Ma
Hongzhen Li
Han Hao
Qi Tang
Kaiwei Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1086517

1,487 views

Correction

Published on 29 Mar 2023

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Yurong Peng
Zhuo Li
Yucheng Fu
Yue Pan
Yue Zeng
Junqi Liu
Chaoyue Xiao
Yingzhe Zhang
Yahui Su
Guoqing Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1163376

604 views

Review

Published on 29 Mar 2023

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective

in Cancer Immunity and Immunotherapy

Ying Li
Shuai Xiang
Wenjun Pan
Jing Wang
Hanxiang Zhan
Shanglong Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1166860

3,042 views
7 citations

Systematic Review

Published on 24 Mar 2023

Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Kefan Chen
Junhao He
Jing Xu
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1088741

1,683 views

Original Research

Published on 24 Mar 2023

Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells

in Cancer Immunity and Immunotherapy

Marine Potez
Sebastian Snedal
Chunhua She
Jongmyung Kim
Konrad Thorner
Timothy H. Tran
Maria Cecilia Ramello
Daniel Abate-Daga
James K. C. Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1124272

2,773 views
2 citations

Navigation group

Articles

The prognostic value of postoperative radiotherapy in right tumor for lung related death: based on SEER database and real-world data

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor

Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma

By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma

Murine macrophage-based iNos reporter reveals polarization and reprogramming in the context of breast cancer

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy

Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination

Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation

Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis

Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective

Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells